Advanced Search



CD33 (PWS44) Mouse Monoclonal Antibody

SIGMA/133M-1

Product Type: Chemical

Catalog Number PKG Qty. Price Quantity
45-133M-14 0.1 mL
$0.00
1/EA
CALL FOR PRICE
Add To Favorites
45-133M-15 0.5 mL
$0.00
1/EA
CALL FOR PRICE
Add To Favorites
45-133M-16 1 mL
$0.00
1/EA
CALL FOR PRICE
Add To Favorites
45-133M-17 1 mL
$0.00
1/EA
CALL FOR PRICE
Add To Favorites
45-133M-18 7 mL
$0.00
1/EA
CALL FOR PRICE
Add To Favorites
Immunohistochemistry CD33 (PWS44) on acute myeloid leukemia

 

antibody form culture supernatant
antibody product type primary antibodies
biological source mouse
clone PWS44, monoclonal
conjugate unconjugated
control acute myeloid leukemia with monocytic
description For In Vitro Diagnostic Use in Select Regions (See Chart)
form buffered aqueous solution
isotype IgG2b
manufacturer/tradename Cell Marque
packaging bottle of 1.0 mL predilute (133M-17)
  bottle of 7.0 mL predilute (133M-18)
  vial of 0.1 mL concentrate (133M-14)
  vial of 0.5 mL concentrate (133M-15)
  vial of 1.0 mL concentrate (133M-16)
Quality Level 100 
  500 
shipped in wet ice
species reactivity human
storage temp. 2-8°C
technique(s) immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:20-1:80
visualization membranous
General description: CD33 (gp67, or siglec-3) is a 67 kDa glycosylated transmembrane protein that is a member of the sialic acid-binding immunoglobulin-like lectin (siglec) family. The genomic locus of this protein has been mapped to chromosome 1 9q1 3.1-3.5. In maturing granulocytic cells, there is progressive down-regulation of CD33 from the blast stage to mature neutrophils. However, in monocytes and macrophages/histiocytes, strong expression of CD33 is maintained throughout maturation. Therefore, the positive control tissue should be bone marrow myeloid cells (especially myeloid precursors), liver Kupffer cells, lung alveolar macrophages, or placental syncytiotrophoblasts. Detection of CD33 using monoclonal antibodies has been a critical component in immunophenotyping acute leukemias, particularly acute myeloid leukemias. This anti-CD33 may be particularly advantageous for cases of acute myeloid leukemia, minimally differentiated (AML-M0) and acute monocytic leukemia (AML-M5), in which other paraffin section markers of myeloid differentiation (such as anti-myeloperoxidase) may be negative. However, anti-CD33 staining cannot be used in isolation and must be correlated with other myeloid and lymphoid markers because cases of myeloid antigen-positive acute lymphoblastic leukemia may show bona fide CD33 expression. In characterizing a blast population, this antibody seems to be most useful when the percentage of blasts is high, such as in acute leukemias. It is not a helpful marker in estimating the percentage of blasts, such as in myelodysplastic syndromes or chronic myeloproliferative disorders, because other early granulocytic precursors such as promyelocytes and myelocytes will also stain with anti-CD33. Acute myeloid leukemias that involve extramedullary tissues frequently have monocytic differentiation. A definitive immunophenotype is often difficult to obtain because these cases may be negative or only focally positive for myeloperoxidase, and the currently available monocytic markers (anti-CD68 and anti-lysozyme) have limited specificity. All cases of myeloid sarcoma in this study showed anti-CD33 positivity in the myeloid and monocytic subsets, allowing for easy interpretation. The excellent sensitivity and specificity for myelomonocytic lineage makes this anti-CD33 a useful diagnostic marker for myeloid sarcoma. In addition, this anti-CD33 may be useful in determining CD33 expression on previous paraffin-embedded material if flow cytometry studies were not initially performed in patients with acute leukemia. Analysis of CD33 expression in paraffin-embedded bone marrow biopsy specimens provides another alternative when evaluating acute leukemias.
Legal Information: Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany
Other Notes: For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
Physical form: Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
Preparation Note: Download the IFU specific to your product lot and format Note: This requires a keycode which can be found on your packaging or product label.
Quality:

IVD

IVD

IVD

RUO
RIDADR NONH for all modes of transport
WGK Germany WGK 2
Flash Point(F) Not applicable
Flash Point(C) Not applicable
Storage Temp. 2-8°C
UNSPSC 12352200

The following items have been added to your cart:

Choose a favorite list for this item:

Catalog Number Description Price
$

Returns/Order support

Please fill out the form below if you want to request order support from Krackeler Scientific.


Quick Order

* Required


New Year Price Updates

We are currently working diligently to update our website pricing information for the New Year. If you place an order, you will be acknowledged with any corrected pricing. If you'd like the most current information sooner, please don't hesitate to drop us an email or give us a call and we'd be happy to assist. Thank you for your patience while we are updating.

800-334-7725
office@krackeler.com


Play Video

To Request a Quote

  1. Search or Browse for items and add to them to your Shopping Cart.
  2. Click the "Request Quote" button at the bottom of the Shopping Cart page.
  3. Fill out required fields.
  4. Optionally you can convert to standard checkout mode by choosing a payment type.
  5. Click "Request Quote" at the bottom of the page.

You will be contacted with a quote.

To Order From a Quote

  1. Register and login to the website.
  2. Receive a quote from your sales representative or customer service.
  3. Have your copy of the quote in hand.
  4. Visit our quote module to search for your quote.
Back to Top